반응 #73895

ord-6e083c1a5e6148538aabf28d53f75cd1

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타the solvent was removed under reduced pressure
  2. 2
    workup.WAITwater (v/v) (80 ml) and left at room temperature for 30 minutes
  3. 3
    기타The bulk of the acetone was then removed under reduced pressure
  4. 4
    기타the residue was partitioned between dichloromethane and 0.5M hydrochloric acid
  5. 5
    기타The organic phase was separated (hydrophobic frit)
  6. 6
    기타evaporated under reduced pressure
  7. 7
    기타The crude product was purified
  8. 8
    세척(Biotage™ flash chromatography column, 90 g silica cartridge eluted with (i) 1:1 ethyl acetate:cyclohexane (ii) ethyl acetate (iii) ethyl acetate:methanol 9:1)

실험 절차

(2RS)-2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N-(2-hydroxyphenyl)ethanamide (2.650 g) was stirred in dichloromethane (20 ml) and carbonyldiimidazole (1.178 g) was added. the mixture was left at room temperature for 16 hours then the solvent was removed under reduced pressure. The residue was then taken up in 1:1 acetone:water (v/v) (80 ml) and left at room temperature for 30 minutes. The bulk of the acetone was then removed under reduced pressure and the residue was partitioned between dichloromethane and 0.5M hydrochloric acid. The organic phase was separated (hydrophobic frit) and evaporated under reduced pressure. The crude product was purified (Biotage™ flash chromatography column, 90 g silica cartridge eluted with (i) 1:1 ethyl acetate:cyclohexane (ii) ethyl acetate (iii) ethyl acetate:methanol 9:1) to afford (2RS)-2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-ethanoic acid as a colourless solid 1.524 g as a mixture of epimers.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08541579B2uspto-grants-2013_09